SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.

Biotechnology

Education

SalioGen Therapeutics

SalioGen Therapeutics' headquarters in Cambridge, MA, United States

Joseph J. Higgins

Will Mcgown

William McGowan

Pat Sacco

Joe Senn

Jill Murray, PHR

LauraLee Hughes

Subhro Guhathakurta

Nancy L. Craig

Bryan Erwin

Oleg Iartchouk

Michelle LeBlanc

Eric Jacquinet

Jesse B. Owens

Thomas Quertermous

Sean Stalfort

John Maraganore

Mark McClellan

Beverly Davidson

Ellis J. Neufeld

Matthew H. Wilson

Sukumar Nagendran

Mathai Mammen

The Scientific Advisory and Development team at SalioGen Therapeutics focuses on advancing the company's EDIT platform through rigorous scientific research and strategic guidance. This multidisciplinary team, comprising directors, advisors, and scientists, collaborates to refine gene therapy processes and ensure the efficacy and safety of SalioGen's non-viral gene therapies, ultimately contributing to the development of potentially curative treatments.

Scientific Advisory and Development

The Scientific Research team at SalioGen Therapeutics focuses on advancing the Exact DNA Integration Technology (EDIT) platform. Their efforts include in vivo biology studies, molecular and cell biology, immunology and oncology research, bioinformatics analysis, and polymeric drug delivery development. Together, these experts conduct cutting-edge research to develop potentially curative non-viral gene therapies derived from mammalian systems.

Scientific Research

The Leadership Team at SalioGen Therapeutics drives the strategic direction and operational excellence of the company, overseeing critical functions such as research and development, manufacturing, and intellectual property management. By leveraging their diverse expertise in genome engineering and gene therapy, they collaborate to enhance the EDIT platform, ensuring the advancement of innovative, non-viral gene therapies that aim to deliver transformative patient outcomes.

Leadership Team

SalioGen Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory and Development

Scientific Research

Leadership Team

Offices

SalioGen Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory and Development

Scientific Research

Leadership Team

Offices

Related companies